Mast cell clones: a model for the analysis of cellular maturation. by Galli, SJ et al.
UCLA
UCLA Previously Published Works
Title
Mast cell clones: a model for the analysis of cellular maturation.
Permalink
https://escholarship.org/uc/item/4ch942fq
Journal
The Journal of cell biology, 95(2 Pt 1)
ISSN
0021-9525
Authors
Galli, SJ
Dvorak, AM
Marcum, JA
et al.
Publication Date
1982-11-01
DOI
10.1083/jcb.95.2.435
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Mast Cell Clones: A Model for the 
Analysis of Cellular Maturation 
STEPHEN J. GALLI, ANN M. DVORAK, JAMES A. MARCUM, TERUKO ISHIZAKA, 
GARY NABEL, H.AROUT DER SIMONIAN, KATHRYN PYNE, JEROLD M. GOLDIN, 
ROBERT D. ROSENBERG, HARVEY CANTOR, and HAROLD F. DVORAK 
Departments of Pathology and Medicine, Beth Israel Hospital and Harvard Medical School, and the 
Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215; kVhitaker College 
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ABSTRACT Cloned mouse mast cells resemble, by ultrastructure, immature mast cells observed 
in vivo. These mast cell clones can be grown in the absence of any other cells, facilitating 
direct investigations of their biochemistry and function. We find that cloned mast cells express 
plasma membrane receptors (Fc~R) that bind mouse IgE with an equil ibrium constant (KA) 
similar to that of normal mouse peritoneal mast cells. In addition, cloned mast cells do not 
display detectable la antigens and cannot enhance Ig secretion when added to lymphocyte 
cultures or mediate natural killer lysis. In the presence of I mM sodium butyrate, cloned mast 
cells stop dividing and acquire abundant electron-dense cytoplasmic granules similar to those 
of mature mast cells. Their histamine content increases concomitant with cytoplasmic granule 
maturation and may exceed that of untreated mast cells by 50-fold. Unlike peritoneal mast 
cells, cloned mast cells incorporate 35S04 into chondroitin sulfates rather than heparin. 1-hese 
findings demonstrate that, unlike fully differentiated mouse peritoneal mast cells, cloned 
immature mouse mast cells contain no heparin and low levels of histamine. In addition, they 
establish that high-affinity Fc, R are expressed early in mast cell maturation, well before 
completion of cytoplasmic granule synthesis and mediator storage. 
We have previously reported methods to clone mast ceils with 
normal karyotypes from mouse hematopoietic tissue in vitro 
(30). Our cloned mast cells contain less histamine than normal 
mouse peritoneal mast cells and resemble immature mast cells 
by morphology. Others have described similar findings with 
uncloned cells (22, 32, 38, 42, 43, 51, 53). Although some mast 
cells synthesize heparin when fully differentiated (23, 54), 
certain mast cell tumors are devoid of heparin and incorporate 
3BSO4 into chondroitin sulfate exclusively (18). Histochemical 
evidence suggests that normal immature connective tissue mast 
cells (6) and the mast cells in the intestinal lamina propria of 
rodents (25, 50) also may synthesize glycosaminoglycans other 
than heparin, but this notion has not been confirmed irectly. 
In this report, we show that cloned mast cells closely resem- 
ble, by ultrastructure, immature mast cells found in vivo. 
Cloned mast cells incorporate 35804 preferentially into chon- 
droitin sulfates, confirming histochemical evidence that im- 
mature mast cells contain little heparin. In addition, cloned 
mast cell proliferation, cytoplasmic granule synthesis, and me- 
diator storage can be modulated in vitro, permitting direct 
analysis of mast cell maturation. 
MATERIALS AND METHODS 
Antisera 
Lyt-1.2 and Lyt-2.2 antisera, prepared as described (45), were kindly donated 
by F. W. Shen~; monoclonal antibody against Thy-l.2 (mc-a-Thy-l.2) was 
donated by Ed Clark2; and mc-a-Lyt-1 and mc-a-Lyt-2 were gifts from J. 
l Memorial Sloan-Kettering Cancer Center, New York, NY 
2 University of Washington, Seattle, WA 
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Ledbetter and L Herzenberg a. Mast cells were examined for la antigens using 
ATH-a-ATL alloantisera (16) or mc-a-Ia (10-3.6, reference 35) generously 
provided by John Freed and J. M. Kupinski 4. 
Mast Cells 
Procedures for the isolation, growth, and cloning of mast cells from mouse 
hematopoietic issue have been previously described (30). Briefly, cells from the 
liver of a 13-d-old mouse fetus from one A/J  female mated with a C57BL/6 
male were incubated in Dulbecco's modified Eagle's medium (DME) with 4% 
heat-inactivated fetal calf serum (FCS), 5 x 10 -s M 2-mercaptoethanol and 2 
mM glutamine (DME-FCS) conditioned by concanavalin A (Con A)-activated 
BALB/c spleen cells (Con A-CM). 10 d later, cells were distributed at limiting 
dilutions in wells containing irradiated (2,000 R) syngeneic bone marrow cells. 
Colonies appeared at 10-14 d with a cloning efficiency of ~10%. All colonies 
grown under these conditions were composed of cells that resembled mast cells 
by light microscopy because of their prominent metachromatic cytoplasmic 
granules. All colonies expressed the Ly 5+ Thy 1-, Ly I-2- phenotype of surface 
membrane glycoproteins. No growth of mast cells was observed from preparations 
of irradiated bone marrow cells. Mast cell lines were cloned by micromanipulation 
(30) and have been designated C1.MC/I-14. The cloned cells have normal 
karyotypes and can be cultivated in large numbers (> 10 s) with doubling times in 
Con A-CM of 36-48 h. Clones are stable for at least 24 too, either alone or with 
an irradiated spleen cell feeder layer, although doubting times of cells maintained 
in Con A-CM may progressively increase. Using similar conditions, mast cell 
colonies also may be isolated from adult mouse spleen or bone marrow cells. 
Treatment of spleen or marrow cells with antiserum to Thy 1.2 and complement 
facilitates growth of mast cell colonies, which by electron microscopy contain 
>95% (usually >99%) mast ceils after 4-6 wk of culture. We have successfully 
maintained our cultures with medium conditioned by Con A-stimulated spleno- 
cytes (Con A-CM), cloned Ly 1+2 - inducer T lymphocytes (31), or WEHI-3 cells 
(32). All the cells described in this report were maintained in Con A-CM unless 
otherwise specified. The active growth factor in the supematant of cloned 
Ly 1+2 - inducer T lymphocytes has been purified to apparent homogeneity. It 
has a pl of-6.0 and a Mr of 45,000 (30) (Nabel et al., manuscript inpreparation). 
Effect of Sodium Butyrate on Mast Cells 
Marl et at. reported that p-815 murine mastocytoma cells, ordinarily devoid 
of cytoplasmic granules, underwent graaulogenesis when exposed to sodium 
butyrate over 3--4 d in vitro (26). Butyrate-induced granulogenesis was accom- 
panied by a prolongation of mastocytoma doubling time and an increase in cell 
size, changes that suggested a differentiation effect. We evaluated whether sodium 
butyrate might exert similar effects on our mast cell clones. In these xperiments, 
mast cells (1 x 105 cell/ml) were cultured in Con A-CM containing 10-20% 
medium conditioned by Ly 1+2 - inducer T lymphocytes (31 ) supplemented with 
various concentrations of sodium butyrate (Pfaltz and Bauer, Stamford, CT) for 
4 d. In some experiments, l-ml aliquots of cells were cultured in 24-well plates 
(Costar, Data Packaging, Cambridge, MA). In other experiments, 5- to 10-ml 
aliquots of cells were seeded into 25 cm '~ tissue culture flasks (Falcon Labware, 
Oxnard, CA). The medium, including butyrate, was replaced after 48 h of culture. 
After 4 d, cells were recovered for electron microscopy and for determination f 
cell number and histamine content. 
Transmission Electron Microscopy (TEM) 
and Autoradiography 
Cells were fixed in suspension for 1 h at room temperature in a mixture of 
paraformaldehyde and glutaraldehyde (9), were washed twice in 0.1 M sodium 
cacodylate buffer, pH 7.4, and were centrifuged through soft agar in a microfuge. 
The agar-embedded pellets were then processed for electron microscopy either 
by the osmium-potassium ferrocyanide (OPF) or osmium-collidine uranyl en 
bloc (OCUB) techniques (9). They were then dehydrated in a graded series of 
alcohols and infiltrated and embedded in a propylene oxide-Epon sequence. For 
autoradiography, asS-labeled cells (see below) were fixed and processed by the 
OCUB techniques as above. Thin Epon sections were cut with an LKB 5 
-ultratome (LKB Instruments, Rockville, MD), were placed on copper grids and 
looped with llford L-4 emulsion, exposed for up to 4 mo under desiccated 
conditions at 4°C, developed with Microdol X (Kodak), and stained lightly with 
lead citrate. Sections were examined in a Philips 400 electron microscope. 
Histamine Determination 
Histamine was routinely measured fluorometrically with an Autoanalyzer II 
3 Stanford University, Stanford, CA  
4 Johns Hopkins University, Baltimore, MD 
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(Technicon Instruments Corp., Tarrytown, NY) equipped to detect histamine in 
the 0.5-10 ng/ml range (46). The histamine content of some samples was also 
determined before and after treatment with diamine oxidase by the isotopic- 
enzymatic method (44), with similar esults. 
IgE Receptors 
The methods used to enumerate and characterize the binding properties of 
Fc~R have been described in detail (17, 48). Briefly, washed cells were resus- 
pended in MEM or RPMI-1640 medium with 0.01 M EDTA and 10% FCS, pH 
7.4, at 1-30 x l0 s ceUs/ml. Cells in 0.4 ml received 0.05 ml of additional medium 
or medium containing 10 mg/ml noniodinated, affinity purified mouse mono- 
clonal IgE antibody from hybridoma H 1 DNP-~-26 (20). After 15 min at 37°C, 
~2sI-IgE, _.80% bindable to the rat basophilic leukemia cell line (16), at 100 #g/ 
ml was added in 0.05 ml for 90 min at 37°C with constant shaking. Duplicate 
determinations of binding of t2~I-IgE to cells were made by layering 0.2-ml 
aliquots of cells onto 0.2 ml of beat-inactivated FCS and centrifuging the tubes 
in a microfuge. The radioactivity in the cell pellets was measured in a gamma 
counter and the number of ~25I-IgE molecules bound per cell calculated according 
to the formula: 
Mean cpm in cells witlfout excess noniodinated IgE 
- Mean cpm in cells with excess 
noniodinated lgE (nonspecific binding) x 3.2 x l0 s* 
cpm of I ng 12SI-lgE cell number 
The forward rate constant (kl) of IgE binding to MC/9 was measured by 
incubating prewarmed cells (1.3 x 106/ml) with 3/~g/ml of ~z~I-labeled mouse 
monoclonal IgE at 37°C in Dulbeeco's modified Eagle's medium containing 10% 
FCS and 0.01 M EDTA with constant shaking. The binding reaction was stopped 
at various intervals by adding a 133-fold excess of unlabeled IgE. Cells in control 
tubes were incubated with a 133-fold excess of unlabeled IgE before addition of 
z25I-IgE. Nonspecific binding of radioactivity ocontrol cells was subtracted from 
experimental tubes to determine specific binding. The number of IgE receptors 
per cell was determined separately by incubating the cells with l0/Lg/ml of 125I- 
IgE for 90 rain as described above. To measure the dissociation rate (k-0 of IgE 
bound to MC/9, cells (1.3 x 10S/ml) were incubated with 3/~g/ml of t25I-labeled 
mouse monoclonal IgE at 37°C for I h in Ly 1+2 - T lymphocyte-conditioned 
Dulbecco's modified Eagle's medium as described above. Cells were then divided 
into two tubes, centrifuged, and resuspended in fresh medium. A 133-fold molar 
excess of unlabeled IgE or an equal volume of culture medium was added to 
each tube at to. The cells were incubated at 37°C with constant slow rotation and 
residual cell-bound 12bI-tgE was determined at various intervals. 
Synthesis of Sulfated Glycosaminoglycans 
Procedures reported previously for the characterization of guinea pig basophil 
giycosaminoglycans were used with minor modifications (36). 
LABELING OF MAST CELLS WITH laSS]SULFATE: Briefly, c loned mast 
cells (CI.MC/9:5 x l06 cells in 5 ml DME 4%-FCS containing 25% (v/v) Con A- 
CM) were labeled with 1 mCi sodium [~SS]sulfate (New England Nuclear, NEX- 
041) for 4-21 h at 37°C. After labeling, cells were washed three times in DME, 
an aliquot was taken for TEM autoradiographs (see above and reference 36), and 
the remainder was stored at -70°C for biochemical analysis. In addition to 
CI.MC/9, we also labeled uncloned populations of mast cells derived from adult 
spleen (line 1) or bone marrow (line 2) maintained in DME-4% FCS supple- 
mented with medium conditioned by WEHI-3 cells (32) and an uncloned 
population of mast cells derived from bone marrow (line 3) maintained in 10% 
ConA-CM conditioned by cloned Ly 1+2 - T lymphocytes. These preparations 
(>99% mast cells by TEM) were labeled for 12-18 h as above except hat the 
DME lacked unlabeled SO~ during the incubation period. In some experiments, 
mast cells were maintained with or without 1 mM sodium butyrate for 4 d before 
labeling with 3SSO4 as above. 
Normal mast cells were purified from peritoneal cells of 6-wk-old CBA/J mice 
(Jackson Laboratories. Bar Harbor, ME) over a metrizamide gradient as previ- 
ously described (48). After the metrizamide gradient, he ceils were washed twice 
in Minimal Essential Medium with Hanks' salts (Gibco, Grand Island Biological 
Co., Grand Island, NY) with PIPES buffer (0.47 g/liter) and 4% FCS. Cells 
(55-80% mast cells) were labeled with sodium [mS]sulfate for 3~l h in DME 
without unlabeled SO4 supplemented with 4% FCS. 
CHARACTERIZATION OF GLYCOSAMINOGLYCANS: Glycosaminogly- 
cans are long chain polysaccharides consisting of repeating disaccharide units. In 
mast cell granules, glycosaminoglycans relinked to a protein core (23, 54) to 
form proteoglycans. The 3sS-labeled glycosaminoglycans of cultured mast cells 
were characterized by DEAE chromatography and sequential hydrolysis with 
* 1 ng IgE = 3.2 x l09 molecules. 
highly purified mucopolysaccharidases of tablished substrate specificities. 
Thawed aliquots of frozen asS-labeled cells were heated in boiling water for 5 
rain to inactivate endogenous degradative enzymes (34), and then exhaustively 
digested with pronase P, which solubilized >90% of incorporated [3SS]sulfate. 
Glycosaminoglycans were chromatographed on DEAE-Sephadex A-25 (0.8 × 
6.9 cm column) previously equilibrated with 0.15 M NaCI, 0.01 M Tris, pH 7.5. 
Fractions were eluted in 0.5-ml volumes with a two-stage linear gradient of NaCI 
(0.15-2.0 M:2:0--4.0 M) (36). Glycosaminoglycans were then incubated with 
specific mucopolysaeeharidases and the products were chromatographed on
Sephadex G-25 (0.6 x 24.5 cm column) equilibrated with 0.15 M NaCI, 0.01 M 
Tris, pH 7.5. Flow rate was 8 ml/h and fraction volume was 0.3 ml. 
Chondroitin AC and ABC lyases (Miles-Yeda, Elkhardt, Indiana) (41), and 
heparinase (purified from Flavobacterium [19]), were employed according to 
published methods. National Institutes of Health glycosaminoglycan reference 
standards were generously provided by J. A. Cifonelli, University of Chicago, 
Chicago, IL. 
Nonlabeled glycosaminoglycans d degradation products were detected spec- 
trophotometricaUy by the carbazole method of Bitter and Muir (3) with glucu- 
ronolactone as the standard. 
Evaluation of Mast Cells for Accessory Cell and 
Natural Killer Function 
Mast cell clones were examined as previously described for the ability to 
enhance Ig secretion (31) or to mediate NK lysis (29). 
RESULTS 
Ultrastructure 
By TEM, clones MC/5 and MC/9 (Figs. 1 and 2 B) consisted 
entirely of mast cells exhibiting various degrees of maturity, as 
judged both by nuclear and cytoplasmic criteria. Uneloned 
mast cell populations (Fig. 2A, C, and D) contained >99% 
mast cells. Mast cell nuclei were round with occasional nuclear 
membrane indentations, dispersed nuclear chromatin, and oc- 
casional small nudeoli. Rare cells exhibited bilobed nuclei. 
The plasma membrane displayed uniformly distributed, nar- 
row short processes and folds. The cells' most prominent 
ultrastructural feature was cytoplasmic granules similar to 
those described in immature mast cells in vivo (4--6, 24) and in 
uncloned populations in vitro (5, 13, 51). These appeared to 
develop from large empty vacuoles in the active Golgi area 
(Fig. 3A). Vacuoles fdled progressively with small vesicles 
(Figs. 2 and 3 B) and then acquired dense matrix, some in the 
form of progranulelike (4-6, 24) structures (Figs. 2 D, 3 A and 
C). All cultures or clones contained at least a few very imma- 
ture-appearing cells that were devoid of dense granule matrix 
FIGURE 1 Typical immature mast cells from clone MC/5 derived from fetal liver. These mononuclear cells exhibit numerous 
immature granules that appear as large, membrane bounded, focally electron lucent structures containing small vesicles and/or 
dense progranules. Cells also contain mitochondria, cytoplasmic vesicles, and a prominent Golgi area. The cell surfaces are covered 
by short, narrow, uniform processes. Bar, 5/~m. x 2,000. 
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FIGURE 2 Mast cells from mouse bone marrow (line 3: A and C) fetal liver (MC/9: B), and spleen (line 1: D). The mast cells from 
bone marrow and spleen were maintained in WEHI-3 conditioned medium; MC/9 mast cells were maintained in Con A-CM. All 
cells contain a single eccentric nucleus and display short, narrow surface processes. The most immature cells (A) had cytoplasmic 
vacuoles containing only a few vesicles. In more mature cells (B, C), the cytoplasmic vacuoles acquired the features of immature 
mast cell granules. These contained variable proportions of fine, granular material; multiple small, round, extremely dense, 
progranules, and numerous small vesicles. The most mature cells (D) contained many granules rich in progranules. Although all 
populations contained cells of various maturity, line 3 appeared most immature and was comprised predominantly of cells like 
that shown in A. Vesicles and larger vacuoles appeared to originate in the active Golgi areas (indicated by arrows in C). Bars, 4 
#m. A, X 9,000; B, X 5,500; C, x 6,500; D, X 8,500. 
and some were comprised predominantly of such cells (Fig. 
2.4). The cytoplasm also contained mitochondria andsmall 
vesicles. The cells had no cytoplasmic glycogen particles or 
aggregates, which are a feature of basophilic leukocytes and 
other granulocytes but not of mast cells. 
Receptors for Ig f  and Histamine Content 
Mast cell cultures (>99% mast cells by TEM) from bone 
marrow or spleen maintained with WEHI-3 conditioned me- 
dium, and cloned mast cells (MC/9) from fetal iver maintained 
in Con A-CM or in 10% Con A-CM conditioned by Ly 1+2 - 
inducer T lymphocytes, expressed approximately half as many 
plasma membrane r ceptors for IgE as normal peritoneal mast 
cells (Table I). The MC/9 Fc,R bound mouse IgE with an 
equilibrium constant at 37°C similar to that of mature mouse 
peritoneal mast cells (Fig. 4 and Table II). The histamine 
content of our mast cells was much less than that of mature 
peritoneal mast ceils. 
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FIGURE 3 Mast cells from bone marrow (line 2: A and B) and spleen (line 1: C) maintained in WEHI-3 conditioned medium. The 
Golgi region in A contains numerous electron-lucent vesicles and vacuoles and occasional electron-dense progranules (arrows) 
adjacent to immature granules. Vesicle-rich immature granules are shown in B, and granules containing abundant dense matrix, 
in C. Bars, 1/tm. A, x 14,000; B, X 26,200; C, x 22,800. 
Effect of Sodium Butyrate on Mast Cell 
Proliferation, Ultrastructure, and 
Histamine Content 
Cloned mast cells (MC/9) were grown in Ly 1+2 - T lym- 
phocyte-conditioned medium with or without 1 mM sodium 
butyrate. After 4 d, mast cells cultured without butyrate had 
increased sevenfold (8 × l0 s to 5.4 × 106), contained 0.03 pg 
histamine/cell, and had a viability by trypan blue exclusion of 
96%. By ultrastructure, these cells appeared very immature, 
with a few large cytoplasmic vacuoles that contained occasional 
small vesicles but no electron-dense granule matrix (Fig. 5A). 
By contrast, mast cells in l mM sodium butyrate ceased ivid- 
ing, remained viable (87-96% viable cells by trypan blue 
exclusion) and developed numerous cytoplasmic granules con- 
taining abundant electron-dense matrix material (Fig. 5 B) 
similar to that of mature mast cells in vivo. Furthermore, 
butyrate-treated cells stored 50-fold more histamine (1.4 pg/ 
cell) than untreated controls. 
We investigated the effects of sodinm butyrate over an ~ 100- 
fold dose range (Table III). While mast cells grown with 1 mM 
butyrate exhibited profoundly diminished proliferation and 
markedly increased histamine content, mast cells grown in the 
presence of 0.3 mM butyrate were minimally affected. Sodium 
butyrate was toxic to cloned mast cells at concentrations -->2 
mM. 
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Sulfated Glycosaminoglycan Synthesis 
CELLULAR LOCAL IZAT ION OF INCORPORATED 
SODIUM [35S]  SULFATE: TEM autoradiographylocalized sil- 
ver grains to the mast cells' cytoplasmic granules (Fig. 6). 
Although the majority of cells were labeled, the number of 
grains/cell varied widely. In general, the mast cells with the 
TABLE I 
Histamine Content and IgE Receptors (Fc. R) of  Mast 
Cell Lines 
Cell* Histamine S FqR x 10-4/ce11§ 
pg/cell 
Normal mouse perito- 
neal mast cells 
CBA/J 9.4-10.4 32.1 + 7.3 
BALB/c 5.2-10.6 23.0 ± 5.9 
MC/9  mast cell clone 0.1-0.4 12.5 
(fetal liver) 
Mast cell line 1 (spleen) 0.1-0.4 10.4 
Mast cell l ine 2 (bone 0.1-0.7 7.0 
marrow) 
Ly 1+2- /9  ( inducer T 0 0 
lymphocytes) 
YAC-1 (mouse lym- ND 0 
phoma) 
* Normal mouse peritoneal mast cells were purified to :=-88% on a metrizamid 
gradient as described in reference 48. Cultured cells were maintained as 
described in the text. 
:~ Range of 3 to 12 determinations performed over a period of weeks (spleen 
and bone marrow lines maintained in WEHI-3 conditioned medium) to a 
year (MC/9 clones maintained in Con A conditioned medium). Replicate 
simultaneous determinations of histamine content varied by <10%. 
§ Values for CBA/J or BALB/c mast cells are M + SEM of five or six duplicate 
determinations, respectively. Values for cultured cells are means of duplicate 
determinations. 
Lu 
10 5 j  
t 
K 1 = 8.2 x 104M "1 sec-t 
I 1 I I 
30 60 120 180 
TIME ( seconds} 
0.8 
0.61- 
0.4 
K_ 1 = 7.9 x 10-5~ -1 
0.2 
I I I 0 , ,  
/ ', 1.8 3.6 72  
036.6 TIME (seconds x fO -3) 
I 
10.8 
FIGURE 4 Forward rate constant (k l )  of  IgE binding to MC/9  (left). 
Dissociation rate (k - l )  of  IgE bound to MC/9  (right). The data were 
normalized by taking the amount of  IgE bound at to = 1.0. Each 
point is the mean of  dupl icate measurements. 
TABLE II 
Binding Characteristics of IgE to Fc, R on Cloned Mouse Mast 
Cells (MC/9) and Mouse or Rat Peritoneal Mast Cells* 
Cell kl k-1 KA 
Cl. MC/9  
Mouse (BALB/c) peritoneal 
mast cells (49) 
Rat peritoneal mast cells (49) 
M- is  -1 s -1 X M -1 
X 10 5 10  -4  X 10  ~ 
0.82 0.79 1.04 
1.94 1.11 1.75 
1.65 0.21 7.86 
* Association (kl), dissociation (k - l )  and equilibrium (KA) constants were 
determined as described in Materials and Methods. 
FIGURE 5 Cloned mast cells derived from fetal liver (MC/9)  grown in Con A-CM supplemented with 15% Ly 1+2 - inducer T 
lymphocyte-condit ioned medium. The cell in A, cultured wi thout  sodium butyrate, contains cytoplasmic vacuoles with a few 
small vesicles but no electron-dense granule matrix. The cell in B, cultured for 4 d with 1 mM sodium butyrate, has numerous 
cytoplasmic granules rich in electron-dense granule matrix. Bars, 2 #m. x 8,000. 
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most mature granule morphology were most heavily labeled. 
CHARACTERIZATION OF aSS-GLYCOSAMINOGLYCANS. As- 
sessment of the relative charge of the cloned mast cell (MC/9) 
35S-glycosaminoglycans, a  determined by chromatography on 
DEAE cellulose, revealed a macromolecular peak which ap- 
peared coincident with the chrondroitin sulfate reference stand- 
ard (Fig. 7). Chromatography on Sepharose 4B established that 
the 35S-glycosaminoglycans had an average Mr of 20,000 dal- 
tons (Fig. 8). These aSS-macromolecules, and the chondroitin 
sulfate standard, were susceptible to complete hydrolysis to 
disaccharides by chondroitin ABC or AC lyase, but were 
insensitive to heparinase (Fig. 8), indicating that they repre- 
TABLE III 
Sodium Butyrate Decreases Mast Cell Proliferation and 
Increases Mast Cell Histamine Content 
Sodium butyrate Doubling Histamine 
concentration time content 
mM h pg/cell 
0 20.4 0.07 
0.01 20.5 0.06 
0.04 20.5 0.06 
0.11 21.5 0.06 
0.33 25.8 0.08 
1.00 132.0 0.50 
Cloned mast cells (MC/9) were cultured for 4 d with or without sodium 
butyrate as described in the text. 
15 
DEAE 
[3SS ] .,=';~ 
SULFATE AT~ = 4 h 
K F 
o "~" 
o Io -~o- 3o 40 
,~2f h 
50 60 
t5 
0.5 
0 
70 
FRACTION VOLUME ( ml ) 
FIGURE 7 DEAE-Sephadex A-25 column (0.8 X 6.9 cm) chromatog- 
raphy of pronase-digested cloned mast cells (MC/9) labeled with 
[aSS]sulfate for 4 or 21 h (see text). The bar indicates the elution 
pattern of the chondroitin sulfate reference standard. 
I0 
8 
=¢ 
6 
2 
0 
I0 
Dextron Hep 
Bl~e Ch~S HS NaCI 
, I l 
14 18 22 26 30 34 
FRACTION VOLUME (ml) 
FIGURE 8 Sepharose 48 column (0.6 X 110 cm) chromatography of 
pronase-digested cloned mast cells (MC/9) labeled with [aSS]sulfate 
for 21 h (see text). The column was calibrated with Dextran Blue, 
National Institutes of Health reference standard glycosaminoglycans 
(Ch-6-S, chondroitin-6-sulfate; HS, heparan sulfate; Hep, heparin), 
and NaCl. 
FIGURE 6 Electron microscopic autoradiography of 35S-labeled im- 
mature granules in a closed mouse mast cell (MC/9) after a 2-too 
exposure of emulsion. Most silver grains appear over the large, 
vesicle-rich cytoplasmic granules. Bar, 2 #m. x 6,000. 
sented chondroitin ABC or AC lyase-sensitive chondroitin- 
sulfates without detectable heparin or dermatan sulfate (chon- 
droitin sulfate B). Similar sulfated glycosaminoglycans were 
synthesized by mast cells incubated with 35SO4 for 4, 12 (data 
not shown), and 21 h. By single dimensional electrophoresis 
(49), these molecules had charge characteristics similar to those 
of the chondroitins. Mast cells from spleen (line 1) or bone 
marrow (line 2 and line 3) also incorporated 3sSO4 into chon- 
droitin sulfates, not heparin. MC/9 or bone marrow line 3 mast 
cells, cultured for 4 d with 1 mM sodium butyrate, synthesized 
35S-glycosaminoglycans identical to those of mast cells grown 
without butyrate, as judged by DEAE cellulose chromatogra- 
phy and susceptibility to enzymatic degradation. Although it 
did not induce synthesis of heparin, butyrate augmented mast 
cell storage of chondroitin sulfate. For example, butyrate- 
treated bone marrow mast cells (line 3) contained 81% more 
[3SS]chondroitin sulfates after an 18-h incubation with 3SSO4 
than untreated controls. Chromatographic (DEAE) analysis of 
mast cell culture medium failed to detect secreted 35S-macro- 
molecules. 
In contrast to cloned mast cells, uncloned peritoneal mast 
cells incorporated 35SO4 predominantly into heparin. These 
glycosaminoglycans eluted from DEAE cellulose as a single 
peak between 1.0 and 2.0 M NaCI. These 35S-macromolecules, 
and the heparin reference standard, were susceptible to hy- 
drolysis to disaccharides by heparinase but were insensitive to 
chondroitin ABC or AC lyase. 
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F~GURE 9 Sephadex G-25 column (0.6 x 24.5 cm) chromatography 
of aliquots of pronase-digested asS-labeled cloned mast cells 
(MC/9) without additional treatment (control) or after treatment 
with purified heparinase or chrondroitin ABC or AC lyase (chondro- 
itinase ABC or AC). Bars indicate the elution patterns of native 
glycosaminoglycan standards (GAG) and their disaccharide degra- 
dation products (DS). The MC/9 macromolecules labeled with ass 
during either a 4- or 21-h incubation were degraded to disaccharides 
by chondroitin ABC or AC lyase, but were unaffected by heparinase. 
Accessory Cell Function and Natural Killer Lysis 
Mast cells from three clones derived from fetal liver were 
unable to alter Ig secretion when added to enriched B lympho- 
cytes. Data from a typical experiment are shown in Table IV. 
Analysis of mast cell clones with monoclonal ntisera failed to 
detect Ia antigens. 
Three mast cell clones from fetal liver or bone marrow did 
not lyse the YAC-I, EL-4, RL-12, and MBL-2 lymphomas and 
the P815 mastocytoma. A representative experiment is shown 
in Table V. 
DISCUSSION 
Cloned mast cells resembled by ultrastructure proliferating 
immature mast cells found in vivo (4-6, 24). Like immature 
mast cells, these clones contained cytoplasmic granules with 
numerous small vesicles and various amounts of electron dense 
progranulelike structures. Despite their immature appearance 
by ultrastructure and their low histamine content, cloned mast 
cells expressed nearly as many Fc,R as mature peritoneal mast 
cells. In addition, the Fc,R of cloned mast ceils bound IgE with 
an equilibrium constant similar to that of normal mouse peri- 
toneal mast cells. Uncloned rat mast cells also express Fc, R 
when their histamine content is very low (14), supporting the 
notion that incorporation of Fc,R into the plasma membrane 
represents an early event in the program of mast cell differen- 
tiation. While some mast cell-like lines reportedly bear Ia 
antigens (42, 51), mouse (7, 52) and rat (28) mature peritoneal 
mast cells do not express Ia antigens detectable by alloantisera. 
We have not detected Ia antigens on the surface membranes of
cloned mast cells by immunofluorescence with monoclonal 
reagents. Although expression may vary according to culture 
conditions, degree of differentiation (47), or source of antisera, 
we have not observed Ia expression at any time with the ceils 
described in this report. 
The relationship of mast ceils to basophils has been widely 
discussed (12). Basophils are bone marrow-derived granulo- 
cytes that normally circulate in the blood and, unlike mast 
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cells, are not ordinarily found in connective tissues. Although 
basophils and mast cells express certain biochemical nd func- 
tional similarities, they are not identical. Electron microscopy 
can be used to distinguish basophils from mast cells in all 
mammalian species, including the mouse (8, 10). Ultrastruc- 
turally, our cloned mast cells resemble immature mast cells 
found in vivo, not mouse basophils. Mouse basophils lack the 
uniform surface processes of normal and cloned mast cells, 
have a more central and polylobed nucleus, and have cyto- 
plasmic granules that are fewer, larger, and different in ultra- 
structure than those of mast cells (10). Mouse tissue mast cells 
and granulocytes may share a common hematopoietic precur- 
sor (15), although the morphology of this precursor cell, and 
the factor(s) that control its division and differentiation, have 
not been described. We do not know whether our cloned cells 
are committed to the mast cell lineage alone; however, we have 
not observed the development of other cell types using the 
culture conditions described in this study. 
We have recently reported that a cloned mouse cell line 
mediating natural killer lysis (29) resembles immature baso- 
phils by ultrastructure and expresses high affinity FC,R (11). 
In the present study, cloned immature mast cells were devoid 
of natural killer cell activity. We have also tested the ability of 
mast cell clones to regulate other immune functions. Mast cell 
clones do not enhance B cell Ig secretion. To date, we have not 
observed inhibition of Ig secretion by cloned mast cells (data 
not shown). However, histamine (37, 39) and perhaps other 
mediators released by mast cells may influence T lymphocyte 
activity, and we are currently testing whether Ig secretion is 
affected by cloned mast cells sensitized with IgE and degran- 
ulated with antigen. 
We have been able to regulate mast cell proliferation and 
induce maturation i vitro. Cloned mast cells grown in medium 
conditioned by Ly 1+2 - T lymphocytes (see Materials and 
Methods) divided with a doubling time of ~20 h. These cells 
TABLE IV 
Mast Cells Do Not Activate B Cells to Secrete Ig 
No. of Ig-secreting cells after 
No. of T lym- addition of 
phocytes or 
mast cells x Mast ceils 
10-4/culture T lymphocytes (MC/9) 
0 104 - -  
1 ND 42 
2 ND 65 
5 ND 117 
10 1053 ND 
20 1313 ND 
25 ND 39 
Ly 1 + T lymphocytes or cloned mast cells were added to 5 x 108 B cells and 
incubated for 5 d. ND, not done, 
TABLE V 
Mast Cells Do Not Mediate NK Lysis 
Specific lysis mediated by 
Effector:Target N K-1 N K-2 MC/9 
% % % 
10:1 36 39 0 
5:1 38 40 0 
2.5:1 35 34 0 
Mast cells (MC/9) or cells with natural killer function (NK-1, NK-2) were 
incubated with 51Cr-labeled YAC-1 lymphoma targets for 3.5 h. 
appeared very immature by ultrastructure and contained only 
a few cytoplasmic vacuoles devoid of electron-dense granule 
matrix. Their histamine content was very low. By contrast, 
mast cells grown in the same medium supplemented with 1 
mM sodium butyrate stopped dividing, developed more mature 
cytoplasmic granules containing increased levels of 35S-glycos- 
aminoglycans, and stored up to 50 times more histamine than 
control mast cells without butyrate. These findings are consist- 
ent with earlier work identifying the cytoplasmic granule as the 
site of histamine storage in mature mast ceils (1). 
The cloned mast ceils described in this report may represent 
a subset which grows under selective culture conditions. Al- 
though there is no proof that mast ceils in vivo are comprised 
of distinct subpopulations, variations in the morphology and 
histochemistry of mast cells in different tissues have suggested 
this possibility. For example, microspectrophotometric analysis 
suggests that the sulfated glycosaminoglycans of rat intestinal 
mucosal mast cells, like those of our clones, are similar to 
chondroitin sulfates (50). Mucosal mast ceils also resemble 
mast ceil clones in their low histamine content (2, 25) and 
responsiveness to T lymphocyte regulation (21, 33, 40). How- 
ever, mouse mucosal mast cells have not been isolated, and 
their glycosaminoglycans have not been analyzed by hydrolysis 
with purified mucopolysaccharidases. The number and IgE 
binding affinity of their Fc, R have not been determined. 
Although the extent and causes of mast cell phenotypic varia- 
tion remain to be fully defined, some differences among mast 
cell populations may be regulated by microenvironmental fac- 
tors affecting morphology, mediator content, or maturation. In 
this view, the ultrastructure and mediator content of cloned 
mast cells may reflect their immaturity or the influence of their 
culture conditions, rather than their derivation from a distinct 
mast cell subpopulation. In support of this notion, histochem- 
ical evidence has suggested that, like mucosal mast cells, im- 
mature connective tissue mast cells in vivo contain little or no 
heparin (6). In addition, cloned mast cells resemble immature 
connective tissue mast cells by ultrastructure (4-6, 24). On the 
other hand, certain mastocytoma sublines reportedly synthesize 
heparin, albeit in small quantities, while they are rapidly 
dividing and their mediator content is very low (27). By con- 
trast, we have not detected heparin synthesis in our cloned 
mast cells even after using butyrate to halt proliferation and 
induce maturation. Whether other agents may induce further 
maturation and synthesis of heparin remains to be determined. 
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